Drugs from the deep: marine natural products as drug candidates
Top Cited Papers
- 17 June 2003
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (12) , 536-544
- https://doi.org/10.1016/s1359-6446(03)02713-2
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPKJournal of Biological Chemistry, 2003
- Aplidin™ induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C δOncogene, 2002
- Chemical diversity: independent of functional diversityTrends in Pharmacological Sciences, 2002
- Functional versus chemical diversity: is biodiversity important for drug discovery?Trends in Pharmacological Sciences, 2002
- Antiangiogenic activity of aeroplysinin‐1, a brominated compound isolated from a marine spongeThe FASEB Journal, 2001
- A New Tyrosine Kinase Inhibitor from the Marine Brown Alga Stypopodium zonaleJournal of Natural Products, 1999
- REGULATION AND INHIBITION OF PHOSPHOLIPASE A2Annual Review of Pharmacology and Toxicology, 1999
- The Marine Natural Product, Halistanol Trisulfate, Inhibits pp60v-src Protein Tyrosine Kinase ActivityBiochemical and Biophysical Research Communications, 1994
- Amino Acid Derivatives from the Marine Sponge Jaspis digonoxeaJournal of Natural Products, 1994
- Marine sponge polyketide inhibitors of protein tyrosine kinaseBiochemical and Biophysical Research Communications, 1992